Role of hospital and patient factors in the outcome of reoperations for primary hyperparathyroidism: a retrospective multicenter cohort study.
Journal
International journal of surgery (London, England)
ISSN: 1743-9159
Titre abrégé: Int J Surg
Pays: United States
ID NLM: 101228232
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
received:
29
05
2023
accepted:
11
07
2023
medline:
27
11
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
epublish
Résumé
There are few data on outcomes after reintervention for persistent or recurrent primary hyperparathyroidism (PHPT). The authors hypothesized that the variation in outcomes at the hospital level after reoperation would be significant. After accounting for this variability, some patient-level clinical criteria could be identified to help inform treatment decisions in this patient population. The aim of this study was to determine whether there is significant variation in outcomes after reoperation for PHPT between hospitals (hospital-level analysis) and identify clinical factors (patient-level analysis) that influence postoperative outcomes. This retrospective multicenter cohort study was performed using the Eurocrine registry. Data from 11 countries and 76 hospitals from January 2015 to October 2020 were extracted. A generalized linear mixed model was used to assess the variation in outcomes at the hospital level and to identify risk factors of postoperative outcomes at the patient level. The primary endpoint (textbook outcome) was achieved when all six of the following postoperative conditions were met: no hypocalcemia or persistent hypercalcemia, no laryngeal nerve injury, no negative exploration, no normal parathyroid gland only on histopathology, and no postoperative death. Among 13 593 patients who underwent parathyroidectomy for PHPT, 617 (4.5%) underwent reoperative parathyroidectomy. At follow-up, 231 patients (37.4%) were hypocalcemic, 346 (56.1%) were normocalcemic without treatment, and 40 (6.5%) had persistent hypercalcemia. Textbook outcomes were achieved in 321 (52.0%) patients. The hospital-level variation in textbook outcome rates was significant ( P <0.001), and this variation could explain 29.1% of the observed outcomes. The criterion that remained significant after controlling for inter-hospital variation was 'a single lesion on sestamibi scan or positron emission tomography (PET) imaging' (odds ratio 2.08, 95% confidence interval 1.24-3.48; P =0.005). Outcomes after reoperation are significantly associated with hospital-related factors. A 'single lesion observed on preoperative sestamibi scan or PET' appears relevant to select patients before reoperation.
Sections du résumé
BACKGROUND
BACKGROUND
There are few data on outcomes after reintervention for persistent or recurrent primary hyperparathyroidism (PHPT). The authors hypothesized that the variation in outcomes at the hospital level after reoperation would be significant. After accounting for this variability, some patient-level clinical criteria could be identified to help inform treatment decisions in this patient population. The aim of this study was to determine whether there is significant variation in outcomes after reoperation for PHPT between hospitals (hospital-level analysis) and identify clinical factors (patient-level analysis) that influence postoperative outcomes.
MATERIALS AND METHODS
METHODS
This retrospective multicenter cohort study was performed using the Eurocrine registry. Data from 11 countries and 76 hospitals from January 2015 to October 2020 were extracted. A generalized linear mixed model was used to assess the variation in outcomes at the hospital level and to identify risk factors of postoperative outcomes at the patient level. The primary endpoint (textbook outcome) was achieved when all six of the following postoperative conditions were met: no hypocalcemia or persistent hypercalcemia, no laryngeal nerve injury, no negative exploration, no normal parathyroid gland only on histopathology, and no postoperative death.
RESULTS
RESULTS
Among 13 593 patients who underwent parathyroidectomy for PHPT, 617 (4.5%) underwent reoperative parathyroidectomy. At follow-up, 231 patients (37.4%) were hypocalcemic, 346 (56.1%) were normocalcemic without treatment, and 40 (6.5%) had persistent hypercalcemia. Textbook outcomes were achieved in 321 (52.0%) patients. The hospital-level variation in textbook outcome rates was significant ( P <0.001), and this variation could explain 29.1% of the observed outcomes. The criterion that remained significant after controlling for inter-hospital variation was 'a single lesion on sestamibi scan or positron emission tomography (PET) imaging' (odds ratio 2.08, 95% confidence interval 1.24-3.48; P =0.005).
CONCLUSION
CONCLUSIONS
Outcomes after reoperation are significantly associated with hospital-related factors. A 'single lesion observed on preoperative sestamibi scan or PET' appears relevant to select patients before reoperation.
Identifiants
pubmed: 37578454
doi: 10.1097/JS9.0000000000000613
pii: 01279778-990000000-00546
pmc: PMC10651301
doi:
Substances chimiques
Technetium Tc 99m Sestamibi
971Z4W1S09
Parathyroid Hormone
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3441-3449Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Minisola S, Arnold A, Belaya Z, et al. Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism. J Bone Miner Res 2022;37:2315–2329.
Yeh MW, Wiseman JE, Ituarte PH, et al. Surgery for primary hyperparathyroidism. Ann Surg 2012;255:1179–1183.
Donatini G, Marciniak C, Lenne X, et al. Risk factors of redo surgery after unilateral focused parathyroidectomy. Ann Surg 2020;272:801–806.
Bilezikian JP, Khan AA, Clarke BL, et al. The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism. J Bone Miner Res 2022;37:2290–2292.
Wilhelm SM, Wang T, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 2016;151:959–968.
El-Hajj Fuleihan G, Chakhtoura M, Cipriani C, et al. Classical and nonclassical manifestations of primary hyperparathyroidism. J Bone Miner Res 2022;37:2330–2350.
Bilezikian JP. Primary hyperparathyroidism. J Clin Endocrinol Metab 2018;103:3993–4004.
Nilsson M, Ivarsson K, Thier M, et al. Mortality after surgery for primary hyperparathyroidism: results from a nationwide cohort. Br J Surg 2021;108:858–63.
Seib CD, Meng T, Cisco RM, et al. Adverse cardiovascular outcomes among older adults with primary hyperparathyroidism treated with parathyroidectomy vs. non-operative management. Ann Surg 2022;278:e302–e308.
Perrier N, Lang BH, Farias LCB, et al. Surgical aspects of primary hyperparathyroidism. J Bone Miner Res 2022;37:2373–2390.
Silverberg SJ. Primary hyperparathyroidism: management after unsuccessful parathyroid surgery. Br J Surg 2021;108:1400–1401.
Irvin GL, Molinari AS, Figueroa C, et al. Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 1999;229:874–879.
Udelsman R, Donovan PI. Remedial parathyroid surgery. Ann Surg 2006;244:471–479.
Chen H, Wang T, Yen TW, et al. Operative failures after parathyroidectomy for hyperparathyroidism. Ann Surg 2010;252:691–695.
Schneider DF, Mazeh H, Chen H, et al. Predictors of recurrence in primary hyperparathyroidism. Ann Surg 2014;259:563–568.
Abdulla AG, Ituarte PH, Harari A, et al. Trends in the frequency and quality of parathyroid surgery. Ann Surg 2015;261:746–750.
Kazaure HS, Thomas S, Scheri R, et al. The devil is in the details: assessing treatment and outcomes of 6795 patients undergoing remedial parathyroidectomy in the collaborative endocrine surgery quality improvement program. Surgery 2019;165:242–249.
Bergenfeltz A, Van Slycke S, Makay O, et al. European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism. Br J Surg 2021;108:675–683.
Sosa JA, Powe NR, Levine MA, et al. Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1998;83:2658–2665.
Iacobone M, Scerrino G, Palazzo FF. Parathyroid surgery: an evidence-based volume–outcomes analysis. Langenbecks Arch Surg 2019;404:919–927.
Prescott JD, Udelsman R. Remedial operation for primary hyperparathyroidism. World J Surg 2009;33:2324–2334.
Karakas E, Müller HH, Schlosshauer T, et al. Reoperations for primary hyperparathyroidism – improvement of outcomes over two decades. Langenbecks Arch Surg 2013;398:99–106.
Morris LF, Lee S, Warneke CL, et al. Fewer adverse events after reoperative parathyroidectomy associated with initial minimally invasive parathyroidectomy. Am J Surg 2014;208:850–855.
Ramonell KM, Chen H, Lindeman B, et al. Re-operative parathyroidectomy: how many positive localization studies are required ? Am J Surg 2021;221:485–488.
Gray WK, Navaratnam AV, Day J, et al. Volume–outcome associations for parathyroid surgery in England. JAMA Surg 2022;157:581–588.
Mathew G, Agha R. for the STROCSS Group. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 2021;96:106165.
Scandinavian Quality Register for Thyroid Parathyroid and Adrenal Surgery. Annual Report 2016. Accessed 30 April 2020. wwwsqrtpase
Kolfschoten NE, Kievit J, Gooiker GA, et al. Focusing on desired outcomes of care after colon cancer resections: hospital variations in textbook outcome. Eur J Surg Oncol 2013;39:156–163.
Busweiler LA, Schouwenburg MG, van Berge Henegouwen MI, et al. Textbook outcome as a composite measure in oesophagogastric cancer surgery. Br J Surg 2017;104:742–50.
Dimick JB, Staiger DO, Osborne NH, et al. Composite measures for rating hospital quality with major surgery. Health Serv Res 2012;47:1861–1879.
Karthaus EG, Lijftogt N, Busweiler LA, et al. Textbook outcome: a composite measure for quality of elective aneurysm surgery. Ann Surg 2017;266:898–904.
Goldstein H. Multilevel Statistical Models (3rd ed). In: Arnold LE, editor. Halstead Press; 2003.
Breslow NE, Clayton DG. Approximate interference in Generalized Linear Mixed Models (GLMM). J Am Stat Assoc 1993;88:9–25.
Austin PC, Yu JV, Alter DA. Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: should we be analyzing cardiovascular outcomes data differently? Am Heart J 2003;145:27–35.
Bamdad MC, Brown CS, Kamdar N, et al. Patient, surgeon, or hospital: explaining variation in outcomes after colectomy. J Am Coll Surg 2022;234:300–309.
Leyland AH, Groenewegen PP Leyland AH. Apportioning variation in multilevel models. Multilevel Modelling for Public Health and Health Services Research. Springer; 2020.
Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res 2022;37:2293–2314.
Hessman O, Stålberg P, Sundin A, et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 2008;32:774–781.
Parikh A, Grogan RH, Moron FA. Localization of parathyroid disease in reoperative patients with primary hyperparathyroidism. Int J Endocrinol 2020;2020:1–15.
Shen W, Düren M, Morita E, et al. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 1996;131:861–867.
Almquist M, Ivarsson K, Nordenstrom E, et al. Mortality in patients with permanent hypoparathyroidism after total thyroidectomy. Br J Surg 2018;105:1313–1318.